Pico-Salax Colonic Preparation Study: Quantifying Electrolyte and Volume Status Changes

Phase 4

Completed

• Conditions: Hemodynamics; Hyponatremia
• Interventions: Drug: Pico-Salax

• Registration Number: NCT00885430
• Lead Sponsor: Queen's University

Brief Summary

Twenty adult volunteers will be administered Pico-Salax in the usual fashion for colonoscopy with intense monitoring of serum and urine chemistry and hemodynamics.

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07
• Primary Completion: 2008-07
• Study Completion: 2008-09
• Study First Submitted: 2009-04-20
• Study First Submitted QC: 2009-04-21
• Study First Posted: 2009-04-22
• Status Verified: 2015-09
• Last Update Submitted: 2015-09-18
• Last Update Posted: 2015-09-22

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• healthy volunteers older than 45

Exclusion Criteria

• impaired renal function
• congestive heart failure ascites known electrolyte abnormalities

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
Pico-Salax	Pico-Salax	-

Primary Outcome Measures

Name	Time	Method
serum electrolytes	48 hours
patient hemodynamics	48 hours

Trial Locations

Locations (1)

Hotel Dieu Hospital; 🇨🇦 Kingston, Ontario, Canada